|
|
|
|
| LEADER |
01868nam a22003015i 4500 |
| 001 |
978-1-59259-970-7 |
| 005 |
20190618091523.0 |
| 007 |
cr nn 008mamaa |
| 008 |
100301s2006 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781592599707
|
| 024 |
7 |
|
|a 10.1007/978-1-59259-970-7
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Vaccine Adjuvants
|c edited by Charles J. Hackett, Donald A. Harn Jr.
|
| 250 |
|
|
|a 1st ed. 2006.
|
| 260 |
# |
# |
|a Totowa, NJ :
|b Humana Press :
|b Imprint: Humana,
|c 2006.
|
| 300 |
|
|
|a XII, 284 p. 28 illus.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Infectious Disease
|
| 505 |
0 |
|
|a Microbial Pathogenesis and the Discovery of Toll-Like Receptor Function -- Dendritic Cells -- Achieving Transcriptional Specificity in NF-?B-Dependent Inflammatory Gene Expression -- Adjuvants and the Initiation of T-Cell Responses -- Mechanism for Recognition of CpG DNA -- CpG ODN As a Th1 Immune Enhancer for Prophylactic and Therapeutic Vaccines -- Modified Bacterial Toxins -- Glycosylphosphatidylinositol Anchors As Natural Immunological Adjuvants Derived From Protozoan Parasites -- The Immunomodulatory Glycan LNFPIII/Lewis X Functions As a Potent Adjuvant for Protein Antigens -- Immune and Antiviral Effects of the Synthetic Immunomodulator Murabutide -- Effects of QS-21 on Innate and Adaptive Immune Responses -- Monophosphoryl Lipid A and Synthetic Lipid A Mimetics As TLR4-Based Adjuvants and Immunomodulators -- Microparticles and DNA Vaccines.
|
| 650 |
|
0 |
|a Immunology.
|
| 650 |
1 |
4 |
|a Immunology.
|
| 700 |
1 |
|
|a Hackett, Charles J.
|e editor.
|
| 700 |
1 |
|
|a Harn Jr, Donald A.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-1-59259-970-7
|